Bonds & fixed income
PSCHInvescoINDEX
Invesco S&P SmallCap Health Care ETF
$54.75+0.74% vs prior close
395652-WK
Price through Oct 27, 2026 · Flows through Oct 26, 2026. Figures use the latest available records, not a live quote. Fund details retrieved Oct 27, 2026. Holdings snapshot retrieved Oct 27, 2026.
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices, LLC compiles, maintains and calculates the index, which is designed to measure the performance of securities of small-capitalization U.S. companies in the health care sector, as defined by the Global Industry Classification Standard.
PSCH price
Source: Market tape, daily closes; price return, distributions not reinvested
Table
| Date | PSCH close |
|---|---|
| Jul 27, 2026 | $52.91 |
| Jul 28, 2026 | $53.58 |
| Jul 29, 2026 | $53.22 |
| Jul 30, 2026 | $54.36 |
| Jul 31, 2026 | $53.39 |
| Aug 3, 2026 | $53.74 |
| Aug 4, 2026 | $54.07 |
| Aug 5, 2026 | $54.20 |
| Aug 6, 2026 | $54.01 |
| Aug 7, 2026 | $54.99 |
| Aug 10, 2026 | $55.30 |
| Aug 11, 2026 | $55.09 |
| Aug 12, 2026 | $55.23 |
| Aug 13, 2026 | $54.93 |
| Aug 14, 2026 | $55.31 |
| Aug 17, 2026 | $55.34 |
| Aug 18, 2026 | $55.27 |
| Aug 19, 2026 | $56.22 |
| Aug 20, 2026 | $55.27 |
| Aug 21, 2026 | $55.65 |
| Aug 24, 2026 | $55.49 |
| Aug 25, 2026 | $55.70 |
| Aug 26, 2026 | $55.64 |
| Aug 27, 2026 | $55.44 |
| Aug 28, 2026 | $54.65 |
| Aug 31, 2026 | $54.61 |
| Sep 1, 2026 | $54.56 |
| Sep 2, 2026 | $54.88 |
| Sep 3, 2026 | $54.75 |
| Sep 4, 2026 | $54.36 |
| Sep 8, 2026 | $53.92 |
| Sep 9, 2026 | $53.71 |
| Sep 10, 2026 | $53.11 |
| Sep 11, 2026 | $52.95 |
| Sep 14, 2026 | $53.33 |
| Sep 15, 2026 | $53.04 |
| Sep 16, 2026 | $53.13 |
| Sep 17, 2026 | $53.51 |
| Sep 18, 2026 | $52.87 |
| Sep 21, 2026 | $53.24 |
| Sep 22, 2026 | $53.76 |
| Sep 23, 2026 | $52.59 |
| Sep 24, 2026 | $52.65 |
| Sep 25, 2026 | $52.79 |
| Sep 28, 2026 | $53.32 |
| Sep 29, 2026 | $53.08 |
| Sep 30, 2026 | $52.07 |
| Oct 1, 2026 | $51.28 |
| Oct 2, 2026 | $51.63 |
| Oct 5, 2026 | $52.52 |
| Oct 6, 2026 | $51.50 |
| Oct 7, 2026 | $51.50 |
| Oct 8, 2026 | $51.37 |
| Oct 9, 2026 | $52.32 |
| Oct 12, 2026 | $52.65 |
| Oct 13, 2026 | $51.93 |
| Oct 14, 2026 | $51.91 |
| Oct 15, 2026 | $52.92 |
| Oct 16, 2026 | $51.86 |
| Oct 19, 2026 | $52.52 |
| Oct 20, 2026 | $53.74 |
| Oct 21, 2026 | $53.56 |
| Oct 22, 2026 | $54.29 |
| Oct 23, 2026 | $54.00 |
| Oct 26, 2026 | $54.35 |
| Oct 27, 2026 | $54.75 |
Weekly net flows, 3M
Net inflow over the range: +$10M
- Inflow / above zero
- Outflow / below zero
Source: Daily creation and redemption records
Show as table
| Label | Value ($) |
|---|---|
| Jul 27 | $2.1M |
| Aug 3 | $1.6M |
| Aug 10 | $11.6M |
| Aug 17 | $5M |
| Aug 24 | −$2.8M |
| Aug 31 | $550K |
| Sep 7 | $0 |
| Sep 14 | $4.8M |
| Sep 21 | −$1.6M |
| Sep 28 | −$2.6M |
| Oct 5 | −$1.6M |
| Oct 12 | −$1.6M |
| Oct 19 | −$5.7M |
| Oct 26 | $0 |
The desk’s read
Money is leaving — −$11M in net outflows over the past month, about 6.6% of the fund's asset base, while the price has returned +24.3% so far this year. At 0.29% a year it is not the cheapest way in — IWM has a reported fee of 0.19%.
COMPOSED FROM THE FUND’S OWN DAILY RECORDS · UPDATED WITH EACH REFRESH
$175Massets under management
0.29%expense ratio · $29 per $10,000 a year
−$11Mnet flow, trailing month
29Kavg daily volume, 30 days
66holdings · US-domiciled
2010listed April 7, 2010 · beta 0.83
The book at a glance
CELL SIZE IS PORTFOLIO WEIGHT · COLOR IS THE CHANGE IN THE LATEST AVAILABLE SNAPSHOT · TOP 40 POSITIONS
Holdings
| # | Holding | Weight | Price | Day | 52-wk | |
|---|---|---|---|---|---|---|
| 1 | GKOSGLAUKOS | 5.53% | $181.17 | +1.6% | ||
| 2 | PTGXPROTAGONIST THERAPEUTICS | 4.69% | $141.12 | +0.6% | ||
| 3 | TGTXTG THERAPEUTICS | 4.03% | $56.44 | +3.0% | ||
| 4 | ALKSALKERMES | 3.83% | $44.32 | -0.3% | ||
| 5 | LGNDLIGAND PHARMACEUTICALS | 3.17% | $311.73 | +1.1% | ||
| 6 | TFXTELEFLEX | 3.03% | $139.00 | +1.6% | ||
| 7 | MMSIMERIT MEDICAL SYSTEMS | 2.92% | $93.53 | -0.7% | ||
| 8 | RDNTRADNET | 2.61% | $73.54 | +5.0% | ||
| 9 | PTCTPTC THERAPEUTICS | 2.65% | $62.09 | +1.7% | ||
| 10 | CONCONCENTRA GROUP HOLDINGS PARENT INC | 2.44% | $40.00 | -0.5% | ||
| 11 | ITGRINTEGER HOLDINGS | 2.25% | $126.74 | +0.2% | ||
| 12 | INDVINDIVIOR | 2.13% | $34.72 | +0.5% | ||
| 13 | ICUIICU MEDICAL | 2.18% | $163.20 | -1.7% | ||
| 14 | VCYTVERACYTE | 2.02% | $50.28 | +4.3% | ||
| 15 | AMRXAMNEAL PHARMACEUTICALS | 1.97% | $21.44 | +2.0% |
The full book, free with one sign-in.
Top 15 positions are open to everyone. Sign in once and every fund’s complete holdings — plus watchlists and flow alerts — unlock across the network.
Sign in to see all 66Sector weights
- Healthcare97.49%
- Health Technology61.95%
- Health Services19.75%
- Technology Services5.6%
- Commercial Services4.78%
- Finance4.25%
- Financial Services2.06%
- Financials2.05%
- Distribution Services1.96%
- Process Industries1.15%
Source: Portfolio composition, latest disclosure
Show as table
| Item | Value (%) |
|---|---|
| Healthcare | 97.49% |
| Health Technology | 61.95% |
| Health Services | 19.75% |
| Technology Services | 5.6% |
| Commercial Services | 4.78% |
| Finance | 4.25% |
| Financial Services | 2.06% |
| Financials | 2.05% |
| Distribution Services | 1.96% |
| Process Industries | 1.15% |
Country weights
- United States100%
- Ireland3.45%
- Netherlands0.34%
Source: Portfolio composition, latest disclosure
Show as table
| Item | Value (%) |
|---|---|
| United States | 100% |
| Ireland | 3.45% |
| Netherlands | 0.34% |
Performance
| 1 week | +2.2% |
| 1 month | +3.7% |
| 3 months | +3.5% |
| 6 months | +22.9% |
| YTD | +24.3% |
| 1 year | +28.0% |
| 3 years | — |
PRICE RETURN, DISTRIBUTIONS NOT REINVESTED
Net flows
| 1 week | −$540K |
| 1 month | −$11M |
| 3 months | +$10M |
| YTD | −$4M |
| 1 year | −$4M |
CREATION/REDEMPTION DOLLARS, DAILY RECORDS
Monthly net flows
- Inflow / above zero
- Outflow / below zero
Source: Daily creation/redemption records, trailing twelve months
Show as table
| Label | Value ($) |
|---|---|
| Aug | $3.2M |
| Sep | −$2.1M |
| Oct | $0 |
| Feb | −$5.6M |
| Mar | −$13.4M |
| Apr | −$2.9M |
| May | $890K |
| Jun | $6.1M |
| Jul | $3.2M |
| Aug | $15.4M |
| Sep | $3.2M |
| Oct | −$10.9M |
The risk read
21%realized volatility, 30 days (annualized)
19%realized volatility, 1 year
-15.4%deepest fall from a peak, 1 year
-2.6%latest close versus that peak
The top holding is 5.5% of the book; the top ten carry 35%. Spread across 70+ names, it behaves like roughly 46 equally-weighted positions.
VOLATILITY & DRAWDOWN FROM THE DAILY TAPE · CONCENTRATION FROM THE LATEST DISCLOSED BOOK
Options tape
—calls · latest snapshot
—puts · latest snapshot
—put/call ratio
11Kshares traded
| Most-traded holdings, options premium | Bullish | Bearish |
|---|---|---|
| LQDA LIQUIDIA | $2M | $3M |
| GKOS GLAUKOS | $638,579 | $392,529 |
| SDGR SCHRODINGER | $281,917 | $467,137 |
| TMDX TRANSMEDICS GROUP | $433,963 | $192,350 |
| USPH U S PHYSICAL THERAPY | $323,105 | $217,460 |
TODAY’S OPTIONS PREMIUM IN THE FUND’S UNDERLYING NAMES
The case against PSCH
Due diligence cuts both ways. These funds sit on the same shelf and beat PSCH on at least one dimension that matters — the fee, the asset base, or where the money is going.
| Fund | Fee | Assets | Flow, 1M | The case | |
|---|---|---|---|---|---|
| SPDW SPDR Portfolio Developed World ex-US ETF | 0.03% | $40.7B | +$609M | -26bp on fee · 233× the assets · +$609M in over the month | Head-to-head |
| SPMD State Street SPDR Portfolio S&P 400 Mid Cap ETF | 0.03% | $18.4B | +$199M | -26bp on fee · 105× the assets · +$199M in over the month | Head-to-head |
| IJH iShares Core S&P Mid-Cap ETF | 0.05% | $123.5B | +$2.3B | -24bp on fee · 706× the assets · +$2.3B in over the month | Head-to-head |
| IDEV iShares Core MSCI International Developed Markets ETF | 0.04% | $32.4B | +$497M | -25bp on fee · 185× the assets · +$497M in over the month | Head-to-head |
| IGSB iShares 1-5 Year Investment Grade Corporate Bond ETF | 0.04% | $23.7B | +$47M | -25bp on fee · 135× the assets · +$47M in over the month | Head-to-head |